Authors: Zang, DY Goodwin, RG Loken, MR Bryant, E Deeg, HJ

Citation: Dy. Zang et al., Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis, BLOOD, 98(10), 2001, pp. 3058-3065

Authors: Zang, DY Deeg, HJ Gooley, T Anderson, JE Anasetti, C Sanders, J Myerson, D Storb, R Appelbaum, F

Citation: Dy. Zang et al., Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation, BR J HAEM, 110(1), 2000, pp. 217-222

Authors: Zang, DY Lee, KH Lee, JS Lee, JH Kim, WK Kim, SH Kim, WD Kim, DS Kim, JH Kim, BS Cho, YB Kim, DK Kim, KH

Citation: Dy. Zang et al., Phase II trial of a novel platinum analog, SKI 2053R, in patients with previously untreated extensive-stage small-cell lung cancer, AM J CL ONC, 22(5), 1999, pp. 495-498

Authors: Lal, A Zang, DY Millerd, J

Citation: A. Lal et al., Laser-diode-based joint transform correlator for fingerprint identification, OPT ENG, 38(1), 1999, pp. 69-75